Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.

Kolinsky, Michael P; Niederhoffer, Karen Y; Kwan, Edmond M; Hotte, Sebastien J; Hamilou, Zineb; Yip, Steven M; Chi, Kim N; Wyatt, Alexander W; Saad, Fred

Kolinsky, Michael P; Niederhoffer, Karen Y; Kwan, Edmond M; Hotte, Sebastien J; Hamilou, Zineb; Yip, Steven M; Chi, Kim N; Wyatt, Alexander W; Saad, Fred.

Afiliação

Kolinsky MP; Cross Cancer Institute, Edmonton, Alberta, Canada; Department of Oncology, University of Alberta, Edmonton, AB, Canada.
Niederhoffer KY; Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Hotte SJ; Department of Oncology, McMaster University, Hamilton, ON, Canada.
Hamilou Z; Division of Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Yip SM; Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, AB, Canada.
Chi KN; BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada.
Wyatt AW; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia and Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Saad F; Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.

Can Urol Assoc J ; 16(4): 132-143, 2022 Apr.

Article em En | MEDLINE | ID: mdl-34812730

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Can Urol Assoc J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Canadá

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google